(Q35843765)

10 August 2017

Injection drug use and patterns of highly active antiretroviral therapy use: an analysis of ALIVE, WIHS, and MACS cohorts (English)

1 reference

10 August 2017

anti-retroviral agent

0 references

Stephen J Gange

5

0 references

Shruti H Mehta

series ordinal

3

object named as

Shruti H Mehta

1 reference

10 August 2017

2

Elizabeth T Golub

1 reference

10 August 2017

John D Morris

1

1 reference

10 August 2017

Lisa P Jacobson

series ordinal

4

1 reference

10 August 2017

6 June 2007

1 reference

AIDS Research and Therapy

10 August 2017

1 reference

10 August 2017

4

1 reference

10 August 2017

12

1 reference

Initial therapy of HIV infection

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892565

Effectiveness of highly active antiretroviral therapy among HIV-1 infected women

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892565

Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892565

Outcome of a second-line protease inhibitor-containing regimen in patients failing or intolerant of a first highly active antiretroviral therapy.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892565

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892565

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892565

Longitudinal data analysis for discrete and continuous outcomes

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892565

The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892565

The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892565

The elusive gold standard. Future perspectives for HIV adherence assessment and intervention

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892565

Effectiveness of highly-active antiretroviral therapy by race/ethnicity

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892565

Factors and temporal trends associated with highly active antiretroviral therapy discontinuation in the Women's Interagency HIV Study

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892565

Interruption and discontinuation of highly active antiretroviral therapy in the multicenter AIDS cohort study.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892565

A qualitative investigation of antiretroviral therapy among injection drug users

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892565

Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patients

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892565

Discontinuation of potent antiretroviral therapy: predictive value of and impact on CD4 cell counts and HIV RNA levels

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892565

Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents, January 28, 2000 by the Panel on Clinical Practices for Treatment of HIV Infection.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892565

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892565

Interval and Clinical Cohort Studies: Epidemiological Issues

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892565

The Women's Interagency HIV Study. WIHS Collaborative Study Group

14 November 2018

1 reference

12 December 2020

Prevalence and correlates of highly active antiretroviral therapy switching in the Women's Interagency HIV Study

1 reference

12 December 2020

Incidence of Discontinuation of Highly Active Antiretroviral Combination Therapy (HAART) and Its Determinants

1 reference

12 December 2020

Effect of discontinuing antiretroviral therapy on survival of women initiated on highly active antiretroviral therapy

1 reference

12 December 2020

Duration of Highly Active Antiretroviral Therapy Regimens

1 reference

12 December 2020

HIV medication adherence. The intersection of biomedical, behavioral, and social science research and clinical practice

1 reference

12 December 2020

Potential factors affecting adherence with HIV therapy

1 reference

12 December 2020

Identifiers

DOI

10.1186/1742-6405-4-12

1 reference

Dimensions Publication ID

10 August 2017

0 references

1 reference

10 August 2017

PubMed publication ID

17553140

1 reference